Lite Strategy (LITS) Enterprise Value (2010 - 2026)
Lite Strategy (LITS) posted Enterprise Value of $33.2 million for Q1 2026, down 15.3% on a QoQ basis from $39.2 million in Q4 2025, and up 662.57% year-over-year from $4.4 million in Q1 2025.
Analysis
Lite Strategy (LITS) Enterprise Value (2010 - 2026) Analysis & Trends
Lite Strategy has reported Enterprise Value for 17 years, with the latest figure at $33.2 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 662.57% year-over-year to $33.2 million in Q1 2026; TTM through Mar 2026 was $33.2 million, a 662.57% increase from a year earlier, with the FY2025 full-year figure at -$1.6 million, up 91.81% from the prior year.
- Enterprise Value was $33.2 million for Q1 2026 at Lite Strategy, down from $39.2 million in the prior quarter.
- The five-year high for Enterprise Value was $61.2 million in Q3 2025, with the low at -$247.1 million in Q1 2022.
- Average Enterprise Value over 5 years is -$69.3 million, with a median of -$56.9 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value tumbled 4918.52% in 2022, then jumped 662.57% in 2026.
- Over 5 years, Enterprise Value stood at -$205.5 million in 2022, then soared by 63.42% to -$75.2 million in 2023, then jumped by 90.22% to -$7.3 million in 2024, then soared by 634.02% to $39.2 million in 2025, then retreated by 15.3% to $33.2 million in 2026.
- The last three Enterprise Value figures came in at $33.2 million (Q1 2026), $39.2 million (Q4 2025), and $61.2 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 33.24 Mn |
| Dec 31, 2025 | 39.24 Mn |
| Sep 30, 2025 | 61.22 Mn |
| Jun 30, 2025 | -1.55 Mn |
| Mar 31, 2025 | -5.91 Mn |
| Dec 31, 2024 | -7.35 Mn |
| Sep 30, 2024 | -27.91 Mn |
| Jun 30, 2024 | -18.96 Mn |
| Mar 31, 2024 | -84.15 Mn |
| Dec 31, 2023 | -75.16 Mn |
| Sep 30, 2023 | -114.32 Mn |
| Jun 30, 2023 | -56.86 Mn |
| Mar 31, 2023 | -184.61 Mn |
| Dec 31, 2022 | -205.49 Mn |
| Sep 30, 2022 | -210.11 Mn |
| Jun 30, 2022 | -72.03 Mn |
| Mar 31, 2022 | -247.08 Mn |
| Dec 31, 2021 | -4.09 Mn |
| Sep 30, 2021 | 35.61 Mn |
| Jun 30, 2021 | 22.63 Mn |